We became aware of the USFDA's revised guidance on May 7 and acted rapidly to assess that. On May 10, we contacted the medical device establishment licence- holders to indicate that the labelling needed to be changed, and we issued a public advisory on May 11. On May 9, we cancelled the authorization to one company in regard to the KN95 masks.
That's the chronology of our work.